Saturday 17 October 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.

85.81 2.05 −2.33%

Follow SOLV

Alert me

Market cap: $15.0B
P/E: 10.4×
Fwd P/E: 39.0×
Dividend yield: —
F-score: 5/9
Altman Z: 2.22
Beneish M: −2.07
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Solventum Corporation (SOLV) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Solventum Corporation (SOLV) trades at a P/E ratio of 10.4×. Over the past ten years it has ranged from 6.8× (June 2024) to 36.0× (July 2025); the current reading is higher than 50% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and below the Healthcare sector median of 23.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SOLV/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Solventum Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SOLV/metrics/pe-ratio">Solventum Corporation (SOLV) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	8.9×	(63.06%)
FY2024	24.0×	134.03%
FY2023	10.3×	0.00%
FY2022	10.3×	—

Period	P/E ratio	Change
Jun 2026	9.4×	18.00%
Mar 2026	8.0×	(10.37%)
Dec 2025	8.9×	6.24%
Sep 2025	8.4×	(75.99%)
10 more quarters	Free account

Against its own ten years

Low 6.8× High 36.0×

Ten-year median 10.4×

Current reading's percentile 50

Company	P/E ratio
BAX Baxter International Inc. compare	n/m
AVTR Avantor, Inc. compare	n/m
SOLV Solventum Corporation	10.4×
COO The Cooper Companies, Inc. compare	19.8×
ATR AptarGroup, Inc. compare	22.2×
ALGN Align Technology, Inc. compare	25.6×
WST West Pharmaceutical Services, Inc. compare	48.7×
ALC Alcon compare	50.5×
RGEN Repligen Corporation compare	234×
Medical Instruments & Supplies industry median	33.8×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Solventum Corporation (SOLV) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SOLV

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SOLV

Stockrow Weekly